In patients with type 2 diabetes or HF, SGLT2 inhibitors reduce gout-related outcomes.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 37931256.
- Also identified by DOI 10.7326/J23-0081.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Banerjee M, Pal R, Maisnam I, et al. <b>Serum uric acid lowering and effects of sodium-glucose cotransporter-2 inhibitors on gout: a meta-analysis and meta-regression of randomized controlled trials.</b> Diabetes Obes Metab. 2023;25:2697-2703. 37334516.
Medical subject headings
- Diabetes Mellitus, Type 2
- Gout
- Sodium-Glucose Transporter 2 Inhibitors